These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 14103651)

  • 1. [REPEATED THERAPY OF CHRONIC MYELOSES BY COMBINED APPLICATION OF MYLERAN AND IRRADIATION OF THE SPLEEN].
    SVOBODA V
    Neoplasma; 1963; 10():651-63. PubMed ID: 14103651
    [No Abstract]   [Full Text] [Related]  

  • 2. [THERAPEUTIC SYNERGISM AS A PROBABLE EXPLANATION FOR THE COMBINED EFFECT OF X-RAY IRRADIATION AND MYLERAN IN CHRONIC MYELOSES].
    SVOBODA V
    Neoplasma; 1964; 11():95-101. PubMed ID: 14118307
    [No Abstract]   [Full Text] [Related]  

  • 3. [BIOPTIC STUDIES ON THE PROBLEM OF THERAPY-INDUCED BONE MARROW FIBROSES IN CHRONIC MYELOID LEUKEMIA].
    HUNSTEIN W; HARWERTH HG; RAJU S
    Med Klin; 1965 Jun; 60():991-5. PubMed ID: 14306880
    [No Abstract]   [Full Text] [Related]  

  • 4. [Giant nuclei after myleran therapy and spleen irradiation in chronic myeloid leukemia].
    WALLER U
    Pathol Microbiol (Basel); 1960; 23():283-90. PubMed ID: 13842627
    [No Abstract]   [Full Text] [Related]  

  • 5. Is it chronic idiopathic myelofibrosis, myelofibrosis with myeloid metaplasia, chronic megakaryocytic-granulocytic myelosis, or chronic megakaryocytic leukemia? Further thoughts on the nosology of the clonal myeloid disorders.
    Lichtman MA
    Leukemia; 2005 Jul; 19(7):1139-41. PubMed ID: 15902283
    [No Abstract]   [Full Text] [Related]  

  • 6. Busulfan therapy in myeloid metaplasia.
    OISHI N; SWISHER SN; TROUP SB
    Blood; 1960 Jun; 15():863-72. PubMed ID: 14428494
    [No Abstract]   [Full Text] [Related]  

  • 7. [REMOTE RESULTS OF MYELOSAN THERAPY OF CHRONIC MYELOID LEUKEMIA].
    BALGOZHINA SZ
    Probl Gematol Pereliv Krovi; 1963 Aug; 8():18-22. PubMed ID: 14091612
    [No Abstract]   [Full Text] [Related]  

  • 8. PORPHYRIA CUTANEA TARDA ASSOCIATED WITH CHRONIC GRANULOCYTIC LEUKEMIA TREATED WITH BUSULFAN (MYLERAN).
    KYLE RA; DAMESHEK W
    Blood; 1964 Jun; 23():776-85. PubMed ID: 14161411
    [No Abstract]   [Full Text] [Related]  

  • 9. The management of elderly patients with myeloproliferative disorders.
    Tura S
    Hematol Oncol; 1993; 11 Suppl 1():39-41. PubMed ID: 8486340
    [No Abstract]   [Full Text] [Related]  

  • 10. [MELANODERMA IN THE COURSE OF TREATMENT OF CHRONIC MYELOID LEUKEMIA WITH MYLERAN].
    LINQUETTE M; MESMACQUE R; FOSSATI P; GASNAULT JP
    Lille Med; 1965 Mar; 10():289-91. PubMed ID: 14317074
    [No Abstract]   [Full Text] [Related]  

  • 11. [ENERGY METABOLISM OF HUMAN THROMBOCYTES UNDER NORMAL CONDITIONS AND IN POLYCYTHEMIA AND CHRONIC MYELOSIS].
    EGOROVA VA; BLINOVA AI; SEITS IF
    Vopr Med Khim; 1965; 11():35-41. PubMed ID: 14339546
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effects of myleran in 22 cases of chronic myeloid leukemia].
    KENIS Y; DUSTIN P; HENRY JA; TAGNON HJ
    Rev Fr Etud Clin Biol; 1956 Apr; 1(4):435-42. PubMed ID: 13351020
    [No Abstract]   [Full Text] [Related]  

  • 13. [1-4 Dimetanosulfoniloxibutano (GT 41 - myleran) in the treatment of chronic myelogenous leukemia].
    MARINHO HM; MARTINS PC
    Arq Bras Med; 1956; 46(5-6):161-72. PubMed ID: 13363714
    [No Abstract]   [Full Text] [Related]  

  • 14. Combined x-ray and myleran treatment of chronic myelosis.
    SVOBODA V
    Neoplasma; 1959; 6():295-304. PubMed ID: 13835984
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of chronic myeloid leukemia with myleran].
    DUCACH G; GRANIC J; TORIELLO G; UBILLA V; DURANTE N
    Rev Med Chil; 1960 Jan; 88():36-42. PubMed ID: 13818383
    [No Abstract]   [Full Text] [Related]  

  • 16. Myleran in the treatment of chronic myeloid leukaemia.
    GREIG MB
    Acta Haematol; 1956 Sep; 16(3):171-80. PubMed ID: 13354257
    [No Abstract]   [Full Text] [Related]  

  • 17. Chemotherapy of leukaemia. I. Myleran in the treatment of chronic myeloid leukaemia.
    GREIG HB
    S Afr Med J; 1956 Apr; 30(15):357-60. PubMed ID: 13324391
    [No Abstract]   [Full Text] [Related]  

  • 18. [The treatment of patients with chronic myeloid leukemia with myleran in polyclinical conditions].
    MOROZOVA VT
    Probl Gematol Pereliv Krovi; 1960 Mar; 5():23-8. PubMed ID: 14424284
    [No Abstract]   [Full Text] [Related]  

  • 19. [Continuous therapy of chronic myeloid leukemia with myleran (sulfabutin)].
    BEYREDER J; HERZOG E
    Munch Med Wochenschr; 1957 Feb; 99(7):223-6. PubMed ID: 13407686
    [No Abstract]   [Full Text] [Related]  

  • 20. Pathogenetic mechanisms in chronic myeloproliferative disorders: polycythemia vera, essential thrombocythemia, agnogenic myeloid metaplasia, and chronic myelogenous leukemia.
    Tefferi A
    Semin Hematol; 1999 Jan; 36(1 Suppl 2):3-8. PubMed ID: 9930550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.